| Oncology | Lifetime | 48 | US 27 | 99.92 |
| Molecular Biology | Lifetime | 846 | US 500 | 99.55 |
| Cancer Research | Lifetime | 185 | US 95 | 98.97 |
| Biotechnology | Lifetime | 902 | US 276 | 73.08 |
| Oncology | 2021-2025 | 70 | US 28 | 99.61 |
| Molecular Biology | 2021-2025 | 670 | US 193 | 96.36 |
| Cancer Research | 2021-2025 | 174 | US 60 | 90.75 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 701 | US 241 | 83.90 |
| Genetics | 2021-2025 | 981 | US 369 | 54.18 |
| Pancreatic and Hepatic Oncology Research | Lifetime | 2 | US 2 | 99.98 |
| Cancer Genomics and Diagnostics | Lifetime | 22 | US 16 | 99.92 |
| Cancer Cells and Metastasis | Lifetime | 36 | US 28 | 99.69 |
| Epigenetics and DNA Methylation | Lifetime | 68 | US 47 | 99.73 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | Lifetime | 87 | US 41 | 99.49 |
| Hedgehog Signaling Pathway Studies | Lifetime | 37 | US 28 | 99.18 |
| Cancer-related gene regulation | Lifetime | 121 | US 63 | 99.09 |
| Neuroendocrine Tumor Research Advances | Lifetime | 174 | US 82 | 99.24 |
| Pancreatitis Pathology and Treatment | Lifetime | 174 | US 79 | 98.96 |
| RNA modifications and cancer | Lifetime | 681 | US 354 | 98.69 |
| Cancer Research and Treatments | Lifetime | 314 | US 189 | 98.09 |
| Genetic factors in colorectal cancer | Lifetime | 486 | US 227 | 98.26 |
| MicroRNA in disease regulation | Lifetime | 824 | US 234 | 97.67 |
| Cancer-related Molecular Pathways | Lifetime | 811 | US 417 | 97.37 |
| Phagocytosis and Immune Regulation | Lifetime | 194 | US 76 | 96.45 |
| Renal and related cancers | Lifetime | 626 | US 315 | 97.21 |
| Single-cell and spatial transcriptomics | Lifetime | 510 | US 275 | 94.57 |
| Molecular Biology Techniques and Applications | Lifetime | 910 | US 444 | 94.69 |
| Curcumin's Biomedical Applications | Lifetime | 237 | US 42 | 94.05 |
| Cancer Mechanisms and Therapy | Lifetime | 888 | US 339 | 92.26 |
| Telomeres, Telomerase, and Senescence | Lifetime | 961 | US 351 | 88.57 |
| Chromatin Remodeling and Cancer | Lifetime | 648 | US 300 | 87.09 |
| Pancreatic and Hepatic Oncology Research | 2021-2025 | 8 | US 3 | 99.83 |
| Cancer Genomics and Diagnostics | 2021-2025 | 43 | US 22 | 99.55 |
| Epigenetics and DNA Methylation | 2021-2025 | 605 | US 198 | 92.66 |
| Single-cell and spatial transcriptomics | 2021-2025 | 335 | US 151 | 92.68 |
| Phagocytosis and Immune Regulation | 2021-2025 | 97 | US 36 | 89.92 |
| Cancer Cells and Metastasis | 2021-2025 | 899 | US 229 | 84.29 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 711 | US 174 | 83.10 |
| Protein Kinase Regulation and GTPase Signaling | 2021-2025 | 755 | US 318 | 43.35 |
